-
1.
公开(公告)号:US20060183160A1
公开(公告)日:2006-08-17
申请号:US11403512
申请日:2006-04-12
申请人: Ziyang Zhong , Barbara Cordell , Diana Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmoller , Paul Hyslop , Edward Johnstone , Sheila Little , Stephen Queener , Tinggui Yin
发明人: Ziyang Zhong , Barbara Cordell , Diana Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmoller , Paul Hyslop , Edward Johnstone , Sheila Little , Stephen Queener , Tinggui Yin
IPC分类号: G01N33/53
CPC分类号: C12N9/6478 , A61K38/00 , C07K14/4711 , C12N9/6421 , C12Q1/37 , G01N33/6896 , G01N2500/00
摘要: The invention concerns a novel β-secretase, a method of partially purifying this novel β-secretase, and its use in assays to screen for potential drug candidates against Alzheimer's disease and other neurological diseases. The novel β-secretase has an estimated molecular weight of about 32-39 kDa or 22-26 kDa in HEK293 cell membrane extracts and human brain samples, respectively, as calculated from radiation inactivation analysis, and has a pH optimum at about pH 6.5-7.0.
摘要翻译: 本发明涉及一种新颖的β-分泌酶,一种部分纯化该新型β-分泌酶的方法,以及其用于筛选潜在的候选药物对抗阿尔茨海默病和其他神经疾病的测定中的应用。 根据放射灭活分析计算,新型β-分泌酶分别在HEK293细胞膜提取物和人脑样品中具有约32-39kDa或22-26kDa的估计分子量,并且具有约pH6.5〜 7.0。
-
公开(公告)号:US20070224656A1
公开(公告)日:2007-09-27
申请号:US11712211
申请日:2007-02-27
申请人: Barbara Cordell , Frauke Schimmoller , Yu-Wang Liu , Diana Quon
发明人: Barbara Cordell , Frauke Schimmoller , Yu-Wang Liu , Diana Quon
IPC分类号: C12Q1/37
CPC分类号: C12Q1/37 , C07K14/4711 , C12N9/6421 , G01N2500/04
摘要: The present invention is based on the findings that BACE2, a homolog of β-secretase BACE, is able to stimulate processing of APP in a non-amyloidogenic pathway, thereby suppressing the level of Aβ. Accordingly, the present invention provides methods and means for the identification and use of modulators of this unique activity of BACE2 to suppress Aβ production. The compounds identified using the methods and means provided herein may be used as potential candidates for the treatment of Alzheimer's disease and other neurological diseases.
摘要翻译: 本发明基于以下发现:BACE2是β-分泌酶BACE的同源物,能够刺激非淀粉样蛋白生成途径中APP的加工,从而抑制Abeta的水平。 因此,本发明提供了鉴定和使用BACE2独特活性调节剂来抑制Abeta生产的方法和手段。 使用本文提供的方法和手段鉴定的化合物可以用作治疗阿尔茨海默病和其他神经疾病的潜在候选物。
-
公开(公告)号:US07087399B1
公开(公告)日:2006-08-08
申请号:US09566746
申请日:2000-05-09
申请人: Ziyang Zhong , Barbara Cordell , Diana Hom Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmöller , Paul Andrew Hyslop , Edward Marion Johnstone , Sheila Parks Little , Steven Wyatt Queener , Tinggui Yin
发明人: Ziyang Zhong , Barbara Cordell , Diana Hom Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmöller , Paul Andrew Hyslop , Edward Marion Johnstone , Sheila Parks Little , Steven Wyatt Queener , Tinggui Yin
CPC分类号: C12N9/6478 , A61K38/00 , C07K14/4711 , C12N9/6421 , C12Q1/37 , G01N33/6896 , G01N2500/00
摘要: The invention concerns a novel β-secretase, a method of partially purifying this novel β-secretase, and its use in assays to screen for potential drug candidates against Alzheimer's disease and other neurological diseases. The novel β-secretase has an estimated molecular weight of about 32-39 kDa or 22-26 kDa in HEK293 cell membrane extracts and human brain samples, respectively, as calculated from radiation inactivation analysis, and has a pH optimum at about pH 6.5-7.0.
摘要翻译: 本发明涉及一种新颖的β-分泌酶,一种部分纯化该新型β-分泌酶的方法,以及其用于筛选潜在的候选药物对抗阿尔茨海默病和其他神经疾病的测定中的应用。 根据放射灭活分析计算,新型β-分泌酶分别在HEK293细胞膜提取物和人脑样品中具有约32-39kDa或22-26kDa的估计分子量,并且具有约pH6.5〜 7.0。
-
公开(公告)号:US07183070B2
公开(公告)日:2007-02-27
申请号:US10749714
申请日:2003-12-31
IPC分类号: C12Q1/37
CPC分类号: C12Q1/37 , C07K14/4711 , C12N9/6421 , G01N2500/04
摘要: The present invention is based on the findings that BACE2, a homolog of β-secretase BACE, is able to stimulate processing of APP in a non-amyloidogenic pathway, thereby suppressing the level of Aβ. Accordingly, the present invention provides methods and means for the identification and use of modulators of this unique activity of BACE2 to suppress Aβ production. The compounds identified using the methods and means provided herein may be used as potential candidates for the treatment of Alzheimer's disease and other neurological diseases by reducing β-amyloid deposit formation.
摘要翻译: 本发明基于以下发现:BACE2是β-分泌酶BACE的同源物,能够刺激非淀粉样蛋白生成途径中APP的加工,从而抑制Abeta的水平。 因此,本发明提供了鉴定和使用BACE2独特活性调节剂来抑制Abeta生产的方法和手段。 使用本文提供的方法和手段鉴定的化合物可以用作通过减少β-淀粉样蛋白沉积物形成来治疗阿尔茨海默氏病和其他神经疾病的潜在候选物。
-
公开(公告)号:US07033812B2
公开(公告)日:2006-04-25
申请号:US10740865
申请日:2003-12-18
申请人: Ziyang Zhong , Barbara Cordell , Diana Hom Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmöller , Paul Andrew Hyslop , Edward Marion Johnstone , Sheila Parks Little , Steven Wyatt Queener , Tinggui Yin
发明人: Ziyang Zhong , Barbara Cordell , Diana Hom Quon , Yu-Wang Liu , Qiang Xu , Frauke Schimmöller , Paul Andrew Hyslop , Edward Marion Johnstone , Sheila Parks Little , Steven Wyatt Queener , Tinggui Yin
CPC分类号: C12N9/6478 , A61K38/00 , C07K14/4711 , C12N9/6421 , C12Q1/37 , G01N33/6896 , G01N2500/00
摘要: The invention concerns a novel β-secretase, a method of partially purifying this novel β-secretase, and its use in assays to screen for potential drug candidates against Alzheimer's disease and other neurological diseases. The novel β-secretase has an estimated molecular weight of about 32–39 kDa or 22–26 kDa in HEK293 cell membrane extracts and human brain samples, respectively, as calculated from radiation inactivation analysis, and has a pH optimum at about pH 6.5–7.0.
-
公开(公告)号:US06713276B2
公开(公告)日:2004-03-30
申请号:US09886143
申请日:2001-06-20
IPC分类号: C12Q137
CPC分类号: C12Q1/37 , C07K14/4711 , C12N9/6421 , G01N2500/04
摘要: The present invention is based on the findings that BACE 2, a homolog of &bgr;-secretase BACE, is able to stimulate processing of APP in a non-amyloidogenic pathway, thereby suppressing the level of A&bgr;. Accordingly, the present invention provides methods and means for the identification and use of modulators of this unique activity of BACE 2 to suppress A&bgr; production. The compounds identified using the methods and means provided herein may be used as potential candidates for the treatment of Alzheimer's disease and other neurological diseases.
摘要翻译: 本发明基于以下发现:BACE 2是β-分泌酶BACE的同系物,能够刺激非淀粉样蛋白生成途径中APP的加工,从而抑制Aβ的水平。 因此,本发明提供了用于鉴定和使用BACE 2独特活性的抑制Abeta产生的调节剂的方法和手段。 使用本文提供的方法和手段鉴定的化合物可以用作治疗阿尔茨海默病和其他神经疾病的潜在候选物。
-
公开(公告)号:US06670182B1
公开(公告)日:2003-12-30
申请号:US09027258
申请日:1998-02-20
申请人: Rebecca Pruss , John Huggins , Guy Rautmann , Barbara Cordell , Jan Marian Scardina , Ronald P. Mischak
发明人: Rebecca Pruss , John Huggins , Guy Rautmann , Barbara Cordell , Jan Marian Scardina , Ronald P. Mischak
IPC分类号: C12N506
CPC分类号: G01N33/6896 , G01N2500/04 , G01N2500/10
摘要: The invention relates to the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing. More specifically, the invention relates to in vitro assays capable of identifying or quantifying a 4.2 kDa &bgr;-amyloid protein. The present invention also provides for DNA and protein molecules for the design, construction and use of eukaryotic cell lines useful in the identification of inhibitors of &bgr;-amyloid processing.
摘要翻译: 本发明涉及可用于鉴定β-淀粉样蛋白加工抑制剂的真核细胞系的设计,构建和用途。 更具体地,本发明涉及能够鉴定或定量4.2kDaβ-淀粉样蛋白的体外测定。 本发明还提供用于设计,构建和使用可用于鉴定β-淀粉样蛋白加工抑制剂的真核细胞系的DNA和蛋白质分子。
-
公开(公告)号:US06221670B1
公开(公告)日:2001-04-24
申请号:US08821876
申请日:1997-03-21
IPC分类号: G01N3348
CPC分类号: G01N33/6896 , G01N33/5088 , G01N2333/4709 , G01N2800/2821
摘要: The present invention provides methods that can be used to identify &bgr;-amyloid reducing compounds. The present invention is based on the use of organotypic brain slice culturing methods to simultaneously assess the toxicity and &bgr;-amyloid reducing activity of a test compound.
摘要翻译: 本发明提供可用于鉴定β-淀粉样蛋白还原化合物的方法。 本发明基于使用器官型脑切片培养方法来同时评估测试化合物的毒性和β-淀粉样蛋白降低活性。
-
公开(公告)号:US5220013A
公开(公告)日:1993-06-15
申请号:US444118
申请日:1989-11-30
申请人: Phyllis A. Ponte , Barbara Cordell
发明人: Phyllis A. Ponte , Barbara Cordell
CPC分类号: C12N15/86 , C07K14/4711 , C12N15/71 , C12Q1/6883 , G01N33/6896 , A61K2123/00 , A61K38/00 , C12N2710/24143 , C12Q2600/156 , C12Q2600/158 , G01N2800/2821
摘要: DNA sequences encoding the beta-amyloid core protein, and beta-amyloid-related proteins associated with Alzheimer's disease are disclosed. These sequences are used in producing or constructing recombinant beta-amyloid core protein, beta-amyloid-related proteins and recombinant or synthetic immunogenic peptides. These sequences are also used to identify genomic mutations and/or restriction site alterations which are associated with a predisposition to Alzheimer's disease, for purposes of genetic screening. Antibodies generated against the recombinant proteins or immunogenic peptides derived therefrom can be used for cerebral fluid or serum protein diagnosis of Alzheimer's disease.
摘要翻译: 公开了编码β-淀粉样蛋白核心蛋白的DNA序列和与阿尔茨海默病相关的β-淀粉样蛋白相关蛋白。 这些序列用于生产或构建重组β-淀粉样蛋白核心蛋白,β-淀粉样蛋白相关蛋白和重组或合成的免疫原性肽。 为了遗传筛选的目的,这些序列还用于鉴定与阿尔茨海默氏病倾向相关的基因组突变和/或限制性位点改变。 针对重组蛋白产生的抗体或由其衍生的免疫原性肽可用于脑血液或阿尔茨海默病的血清蛋白诊断。
-
公开(公告)号:US20080039461A1
公开(公告)日:2008-02-14
申请号:US11648226
申请日:2006-12-28
申请人: Andrew Protter , Camilla Svensson , Tony Yaksh , Barbara Cordell , Sundeep Dugar
发明人: Andrew Protter , Camilla Svensson , Tony Yaksh , Barbara Cordell , Sundeep Dugar
IPC分类号: A61K31/535 , A61K31/415 , A61K31/445 , A61P25/00 , A61K31/505
CPC分类号: A61K31/381 , A61K31/4164 , A61K31/44 , A61K31/496
摘要: The present invention relates to methods for the prevention or treatment of pain by the inhibition of p38 MAP kinase.
摘要翻译: 本发明涉及通过抑制p38 MAP激酶预防或治疗疼痛的方法。
-
-
-
-
-
-
-
-
-